Boehringer Ingelheim (Reims Operations) Overview

  • Status
  • Acquired/​Merged

  • Employees
  • 465

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Boehringer Ingelheim (Reims Operations) General Information

Description

Manufacturer of pharmaceutical products. The unit manufacture and develop dry dosage forms, liquids and aerosols pharmaceutical drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Private Equity-Backed
Primary Industry
Pharmaceuticals
Acquirer
Delpharm
Primary Office
  • Reims
  • France

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Boehringer Ingelheim (Reims Operations) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Boehringer Ingelheim (Reims Operations)‘s full profile, request access.

Request a free trial

Boehringer Ingelheim (Reims Operations) Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Boehringer Ingelheim (Reims Operations) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Boehringer Ingelheim (Reims Operations)‘s full profile, request access.

Request a free trial